LAA closure and anthrombotic therapies

Facilitators: J. E. Nielsen-Kudsk, A. Tzikas

Speakers: E. Valero, R. Galea, M. Gamardella, V. Eskildsen, F. Schoepen

Summary

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

Presentations available when logged in:

Antithrombotic de-escalation strategy after LAA closure in patients with contraindications to anticoagulation
Impact of P2Y12 inhibitor loading dose after successful percutaneous LAA closure
Efficacy and safety of LAA closure in atrial fibrillation patients with anticoagulation limitations
LAA closure in atrial fibrillation: aetiology and outcomes of breakthrough stroke
Anatomical suitability for LAA closure in patients with high CHADS-VASc score undergoing atrial fibrillation ablation

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

LAA closure and anthrombotic therapies

Log in or create account for free